Health Cluster Portugal: from knowledge to market

You are here:

Homepage Membership Directory iBET - Instituto de Biologia Experimental e Tecnológica

Last update

28-11-2016

iBET - Instituto de Biologia Experimental e Tecnológica

http://www.ibet.pt/

Category(ies): Contract Research Organisations; Public / Nonprofit Organisations; R&D Institutions

Subcluster(s):

Address: Avenida da República, Quinta do Marquês, EAN, Apartado 12; 2781-901 Oeiras; Portugal

Related links:

Keyword(s): Advanced Therapies, Biomedical engineering, Pharmaceuticals, Research & Development, Stem Cells Biotechnology

iBET is a private non-profit research intensive institution with over 25 years of experience in developing innovative solutions for the biopharmaceutical industry, SMEs, academic and private institutions. Key areas of expertise include the bioprocessing, production and in depth analysis of recombinant proteins and monoclonal antibodies, viral vaccines, viral vectors for gene therapy and stem cells for cell therapy applications; and in the development of in-vitro advanced cell models for pre-clinical research (eg. cancer, neural). iBET’s infrastructure comprises 16 cutting edge laboratories, a GMP certified Analytical Services Unit, a Pilot Plant for bioprocess development and production scale up and partners with the GMP manufacturer Genibet (45% owned by iBET, www.genibet.com) for production of biopharmaceutical for phase I/II clinical trials. IBET is also the coordinator of the “iNOVA4Health – Advancing Precision Medicine” Research Unit (www.inova4health.com), which organizes the efforts of biomedical researchers involved in biological understanding of disease, lead compounds and biopharmaceuticals “pre-discovery”, technological scientists involved in “preclinical development”, and clinicians involved in “early clinical and first in man clinical trials”. Trusting partners include international pharmaceutical companies, such as Bayer Healthcare, Novartis Pharma, Merck Serono, Abbvie, Sanoffi, Apceth, AstraZeneca, GSK, Merck & Co.

R&D Projects

Contact person

Goncalo Real

Marketing & Business Development Manager

real@ibet.pt

+351 214 469 361

Service Centres

Announcements/Opportunities